NNES FIRST OWN ANNUAL REVIEW

Main Menu | News By Date | News By Supplier | News By Category | About Us

NNES FIRST OWN ANNUAL REVIEW
07 May 2002 - NNE A/S

2001 was a remarkable year for NNE in every way, characterised by progress and development. With the largest project portfolio ever, resulting in a turnover of more than DKK 1 billion and profit before taxation of DKK 54 million. In 2001 NNE also celebrated its 10-year anniversary as independent subsidiary within the Novo Group.

The wish to be more extrovert led to the 2001 launch of our new visual identity and brand, signalling our ambitions for a more independent market oriented profile.

We can offer expertise and many years of knowledge of the industry to an increasing clientele. And we are a challenging workplace with a unique technical environment that becomes increasingly known and sought-after by our surroundings. Latest a grand 2nd place in the 2002 image poll of the Danish magazine 'Ingeniøren' of the 100 most attractive engineering workplaces in Denmark.

NNE is a company in development in every way. And what would be more natural than to mark this positive trend with our first own Annual Review.

The NNE Annual Review 2001 or the complete financial statements with notes and other detailed information can be ordered with NNE Marketing, see contact.

The material can also be downloaded from the blue bar.

http://nne.dk/

About: NNE A/S
With more than 80 years of experience, the engineering company NNE is a leading supplier of systems, consultancy and engineering services to the international pharmaceutical and biotechnological industry.

Our competencies span all technical disciplines applying to engineering, construction, validation, start-up and optimisation, and reconstruction of facilities for product development and production plants, pilot plants and laboratories within the pharmaceutical and biotechnological field.

Our unmistakable, clear client focus, combined with a flexible and integrated organisation where engineers, architects and pharmacists work closely together, puts us in a position to deliver customised solutions, ranging from stand-alone services to turnkey plants - quickly and safely.

NNE operates at an international level. We have worked on and completed a large number of projects both in Denmark and the rest of Scandinavia, and we have constructed biotechnological and pharmaceutical production facilities in USA, China, Japan, Brazil, and France.

More News:
  • For May 2002
  • From NNE A/S
  • For Medical Equipment